VistaShares Electrification Supercycle ETF POW
22.30 USD -0.08 (-0.38%)
Nov 12, 2026, 11:43 AM EST
21.66 Day range 22.47
18.72 52-week range 35.55
- YTD
- +13.35%
- 1 year
- +9.50%
News
benzinga.com VistaShares Bets the Next AI Winners Will Be Robots, Not Just Chips As AI expands beyond chips into robots and automation, VistaShares is highlighting the growing investment case for robotics ETFs.
benzinga.com Earnings Scheduled For May 12, 2026 - benzinga.com Earnings Scheduled For March 18, 2026
- benzinga.com Earnings Scheduled For November 12, 2025
benzinga.com VistaShares' POW ETF Bets On The Real AI Bottleneck — Power, Not Processors The Electrification Supercycle ETF (POW) targets the energy infrastructure firms upgrading America's grid to meet the AI era's power demands.
benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
benzinga.com Earnings Scheduled For August 5, 2022 Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
benzinga.com Earnings Scheduled For May 11, 2022 Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.- benzinga.com Earnings Scheduled For March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter.
benzinga.com Earnings Scheduled For November 10, 2021 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.- benzinga.com Earnings Scheduled For August 6, 2021 Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.
benzinga.com Earnings Scheduled For May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.